Enfusion (NYSE:ENFN) Sees Large Volume Increase

Shares of Enfusion, Inc. (NYSE:ENFN) saw an uptick in trading volume on Friday . 1,146,530 shares changed hands during trading, an increase of 205% from the previous session’s volume of 375,634 shares.The stock last traded at $9.26 and had previously closed at $8.55.

Enfusion Price Performance

The stock has a market capitalization of $1.18 billion, a P/E ratio of 315.67, a PEG ratio of 2.23 and a beta of 0.90. The stock’s fifty day moving average is $8.52 and its 200-day moving average is $8.86.

Enfusion (NYSE:ENFN) last posted its earnings results on Tuesday, August 6th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.01). Enfusion had a return on equity of 6.17% and a net margin of 1.98%. The company had revenue of $49.46 million during the quarter, compared to analyst estimates of $50.27 million. On average, research analysts expect that Enfusion, Inc. will post 0.07 EPS for the current year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of ENFN. 272 Capital LP raised its position in shares of Enfusion by 1.5% during the second quarter. 272 Capital LP now owns 139,180 shares of the company’s stock valued at $1,186,000 after buying an additional 2,000 shares during the last quarter. California State Teachers Retirement System lifted its position in shares of Enfusion by 11.0% in the 1st quarter. California State Teachers Retirement System now owns 36,002 shares of the company’s stock worth $333,000 after acquiring an additional 3,556 shares during the period. The Manufacturers Life Insurance Company grew its holdings in shares of Enfusion by 27.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 19,562 shares of the company’s stock worth $167,000 after purchasing an additional 4,239 shares in the last quarter. Allspring Global Investments Holdings LLC bought a new stake in shares of Enfusion during the first quarter valued at approximately $44,000. Finally, American Century Companies Inc. increased its position in shares of Enfusion by 17.1% during the second quarter. American Century Companies Inc. now owns 35,897 shares of the company’s stock valued at $306,000 after purchasing an additional 5,253 shares during the period. 81.05% of the stock is currently owned by institutional investors and hedge funds.

About Enfusion

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.